Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients. [electronic resource]
Producer: 20010503Description: 477-81 p. digitalISSN:- 0003-987X
- Adult
- Age Factors
- Aged
- Calcitonin -- therapeutic use
- Calcium -- therapeutic use
- Controlled Clinical Trials as Topic
- Densitometry
- Diphosphonates -- therapeutic use
- Estrogen Replacement Therapy
- Estrogens, Conjugated (USP) -- administration & dosage
- Exercise
- Female
- Fractures, Bone -- prevention & control
- Glucocorticoids -- administration & dosage
- Humans
- Male
- Meta-Analysis as Topic
- Middle Aged
- Osteoporosis -- chemically induced
- Osteoporosis, Postmenopausal -- prevention & control
- Raloxifene Hydrochloride -- therapeutic use
- Risk Factors
- Selective Estrogen Receptor Modulators -- therapeutic use
- Skin Diseases -- drug therapy
- Time Factors
- Vitamin D -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.